Barro, Eduardo D.
HRN: 21-88-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/08/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/08/2022
09/15/2022
IV
4.5grams
Q6h
CVD Prob Bleed; T/C Aspiration Pneumonia; HCVD
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaURTI Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes